- Home
- TROO vs GOSS Comparison
TROO vs GOSS Comparison
Compare TROO & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TROO
- GOSS
- Stock Information
- Founded
- TROO 2005
- GOSS 2015
- Country
- TROO Hong Kong
- GOSS United States
- Employees
- TROO N/A
- GOSS N/A
- Industry
- TROO Radio And Television Broadcasting And Communications Equipment
- GOSS Biotechnology: Pharmaceutical Preparations
- Sector
- TROO Technology
- GOSS Health Care
- Exchange
- TROO Nasdaq
- GOSS Nasdaq
- Market Cap
- TROO 214.9M
- GOSS 237.9M
- IPO Year
- TROO N/A
- GOSS 2019
- Fundamental
- Price
- TROO $1.79
- GOSS $0.92
- Analyst Decision
- TROO
- GOSS Strong Buy
- Analyst Count
- TROO 0
- GOSS 5
- Target Price
- TROO N/A
- GOSS $9.20
- AVG Volume (30 Days)
- TROO 317.1K
- GOSS 1.0M
- Earning Date
- TROO 11-15-2024
- GOSS 03-04-2025
- Dividend Yield
- TROO N/A
- GOSS N/A
- EPS Growth
- TROO N/A
- GOSS N/A
- EPS
- TROO N/A
- GOSS N/A
- Revenue
- TROO $4,344,000.00
- GOSS $105,322,000.00
- Revenue This Year
- TROO N/A
- GOSS N/A
- Revenue Next Year
- TROO N/A
- GOSS N/A
- P/E Ratio
- TROO N/A
- GOSS N/A
- Revenue Growth
- TROO 14.77
- GOSS N/A
- 52 Week Low
- TROO $0.73
- GOSS $0.50
- 52 Week High
- TROO $4.89
- GOSS $1.60
- Technical
- Relative Strength Index (RSI)
- TROO 49.21
- GOSS 50.80
- Support Level
- TROO $1.60
- GOSS $0.83
- Resistance Level
- TROO $2.19
- GOSS $1.04
- Average True Range (ATR)
- TROO 0.20
- GOSS 0.10
- MACD
- TROO 0.01
- GOSS -0.01
- Stochastic Oscillator
- TROO 36.51
- GOSS 30.65
About TROO TROOPS Inc.
TROOPS Inc is a conglomerate group of various businesses with its headquarters based in Hong Kong. The group is principally engaged in money lending business in Hong Kong providing mortgage loans to high quality target borrowers, property investment to generate additional rental income and the development, operation and management of an online financial marketplace that provides one-stop financial technology solutions including API services by leveraging artificial intelligence, large data and blockchain, and cloud computing (SaaS). It derives revenue from Hong Kong and Australia. Majority of its revenue generates from domestic market.
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.